Morphocell Technologies Inc. is a regenerative medicine company focused on the development and commercialization of stem cell therapies and engineered tissue implants that target liver failure. The Company is supported by Series A investment to achieve Phase 1 clinical trials. Morphocell Technologies aims at bringing to market the first effective treatment for acute, chronic and acute-on-chronic liver failure.
| Website | https://www.morphocell.com/ |
| Employees | 50 (40 on RocketReach) |
| Founded | 2018 |
| Address | 275 Boulevard Armand-Frappier, Laval, Quebec H7V 4A7, CA |
| Technologies |
JavaScript
,
HTML
,
Twitter
+9 more
(view full list)
|
| Industry | Biotechnology Research, Biotechnology, Science and Engineering |
| Keywords | Stem Cell Therapy, Regenerative Medicine, Liver Disease Treatment, Liver Failure Treatment, Tissue Engineering, Stem Cell Research, Cell Therapies, Regenerative Medicine Technology, Organ Regeneration, Tissue Repair, Transplantation Medicine, Biotechnology, Cellular Therapy, Biomedical Engineering, Drug Development, Medical Technology, Pharmaceutical, Biopharma, Life Sciences |
| Competitors | Johnson & Johnson, Medtronic, Abbott, Smith+Nephew, Integra LifeSciences, Organogenesis, Acelity, AlloSource®, Tissue Regenix Group, MediWound Ltd. +35 more (view full list) |
Looking for a particular Morphocell Technologies employee's phone or email?
Morphocell Technologies Questions
Massimiliano Paganelli is the Co-Founder and Chief Executive Officer of Morphocell Technologies.
40 people are employed at Morphocell Technologies.
Morphocell Technologies is based in Laval, Quebec.
Top Morphocell Technologies Employees
-
35+
-
25+
-
35+
-
21
Related Companies
